Please complete the CAPTCHA to continue
@medimmune.com
✓
LinkedIn matched
A concise factual answer block for searchers comparing this professional profile.
Samuel Wu is listed as CBO, Blue Lake Biotechnology; Venture Partner, 7G BioVentures at Blue Lake Biotechnology, a with 15 employees, based in Palo Alto, California, United States. AeroLeads shows a work email signal at medimmune.com and a matched LinkedIn profile for Samuel Wu.
Samuel Wu previously worked as Chief Business Officer at Blue Lake Biotechnology and Interim Chief Medical Officer at Blue Lake Biotechnology. Samuel Wu holds Md, Phd, Biochemistry from Stanford University School Of Medicine.
This section adds company-level context without repeating Samuel Wu's masked contact details.
AeroLeads found 1 current-domain work email signal for Samuel Wu. Compare company email patterns before reaching out.
• Venture capital deal professional with broad network and direct experience investing in, serving on the boards of, and otherwise supporting over 20 biotech and medical device startup companies• McKinsey management consulting experience, leading teams in advising clients in corporate finance, commercialization, and portfolio strategy• Broad strategic thinker with top-down (management, board) experience combined with bottom-up fundamental analytic skills as a clinician and PhD scientistSpecialties: Biotechnology and pharmaceuticals; medical devices; business development and licensing; corporate finance and strategy. Therapeutic areas of greatest interest: infectious disease, neuroscience, ophthalmology, inflammation and immunology
Company context helps verify the profile and gives searchers a useful next step.
A career timeline built from the work history available for this profile.
CBO for a clinical stage biotech startup with an intranasal vaccine platform technology. We have an RSV vaccine soon to start a Phase 1/2a study in children and infants, and a COVID vaccine soon to start Phase 2.
Interim CMO for an intranasal vaccine startup running first-in-human Phase 1 clinical trials for their COVID and RSV vaccines.
• Strategic advisor / consultant to biotechnology and med tech startups and VC firms• Interim executive (BD, CBO, CMO) and Board Director positions• Pro bono consultant for several biotech incubator/accelerator programs
Gaithersburg, Maryland, Us
• Head of the West Coast office of the corporate venture capital arm of AstraZeneca• Led investments, negotiated term sheets, executed diligence, sourced deals• Served as a director on five private and public portfolio company boards, including chairing Compensation, Finance, and Nominating and Corporate Governance committees
London, London, Gb
• Identified and qualified early stage companies as potential investments. Sourced (made initial contact with) about 1/4th of SV’s new US therapeutics investments since 2005• Led due diligence on all aspects of potential investments using internal and external resources: preclinical and clinical data and development plans, biostatistics, market and commercialization plans, potential exits and returns, intellectual property, legal diligence• Negotiated terms of investment and/or coordinated closings for ~15 new investments• Supported portfolio companies in various aspects of company strategy including 15+ follow-on financings and M&A exits• Led firm effort to understand diagnostics industry and evaluate potential investments in the sector• Served as board member or observer of several portfolio companies, including Ocular Therapeutix, Halscion, Alba Therapeutics, Juvaris Biotherapeutics, Logical Therapeutics, Sapphire Therapeutics (acquired by Helsinn), Confluent Surgical (acquired by Covidien)
Us
• Led teams of consultants in gathering and analyzing information, developing solutions to problems, and communicating and working with clients• Served pharmaceutical and medical device clients on projects in sales and marketing, research and development, and business development. Examples: - Biologics strategy for a major pharmaceutical company evaluating acquisitions of $5-15 billion biotechnology companies - Diligence on a specialty pharmaceutical business which led to a $500M acquisition by the client - International relaunch of an HIV drug yielding an estimated $200M impact on product revenues• Published practice development documents capturing non-confidential learnings from client work to be shared with other McKinsey colleagues• Led firm’s MD/PhD recruiting effort at the University of Pennsylvania, and led office efforts to launch recruiting and intranet web sites
Quick answers generated from the profile data available on this page.
Samuel Wu works for Blue Lake Biotechnology.
Samuel Wu is listed as CBO, Blue Lake Biotechnology; Venture Partner, 7G BioVentures at Blue Lake Biotechnology.
AeroLeads has found 1 work email signal at @medimmune.com for Samuel Wu at Blue Lake Biotechnology.
Samuel Wu is based in Palo Alto, California, United States while working with Blue Lake Biotechnology.
Samuel Wu has worked for Blue Lake Biotechnology, 7G Bioventures, Acuris Partners, Medimmune Ventures, and Sv Life Sciences.
You can use AeroLeads to view verified contact signals for Samuel Wu at Blue Lake Biotechnology, including work email, phone, and LinkedIn data when available.
Samuel Wu holds Md, Phd, Biochemistry from Stanford University School Of Medicine.
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial Search contacts